Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2007
10/10/2007CN101049352A Method for preparing short-pedicel aconite root of Chinese traditional medicine
10/10/2007CN101049351A Composition of Chinese traditional medicine for treating prolapse of lumbar intervertebral disc
10/10/2007CN101049335A Injection of general flavone of epimedium
10/10/2007CN101049329A Application of angelica oil in raising level of estradiol from internal source for treating estradiol related disease
10/10/2007CN101049327A Application of gambogicacid in preparing medication for restraining angiogenesis
10/10/2007CN101049310A Nerve block injection, and preparation technique
10/10/2007CN101049301A Pharmaceutical preparation of biflavone compound for anti gout
10/10/2007CN101049284A Whitening frost of anti bud and preventing coarseness
10/10/2007CN101049157A Functional health food for preventing osteoporosis
10/10/2007CN100341576C Adhesive patch
10/10/2007CN100341557C Externally applied plaster
10/10/2007CN100341540C Angelica root mistletoe granules and its preparation method
10/10/2007CN100341489C Xianling gubao dripping pills having functions of reinforcing kidney strengthening bone, and its prepn method
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279484 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007CA2161857C Oxazolidinone derivatives as adhesion receptor antagonists
10/06/2007WO2008125901A2 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
10/04/2007WO2007112093A2 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007111038A1 Aggrecanase production inhibitor
10/04/2007WO2005039546A3 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
10/04/2007US20070232658 Protein Kinase C Inhibitors for the Treatment of Autoimmune Diseases and of Transplant Rejiction
10/04/2007US20070232631 1-[4-(5-Bromopyrimidin-2-ylsulfanyl)phenyl]-3-(2-nitrobenzoyl)-urea; antiproliferative, water soluble compound with high bioavailability
10/04/2007US20070232628 Calcium receptor antagonists; 2-(2-hydroxy-phenyl)-3-(4-isopropyl-phenyl)-5,6,7,8-tetrahydro-3H-quinazolin-4-one; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral hypercalcemia, osteoporosis
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232579 Nitrated Lipids and Methods of Making and Using Thereof
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231309 Cell populations which co-express CD49c and CD90
10/04/2007US20070231275 Method for regenerating tooth germ
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007CA2647237A1 Ingestible compositions containing extracts
10/04/2007CA2645496A1 Gdf-9/bmp-15 modulators for the treatment of bone disorders
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839671A2 Attenuation of fibroblast proliferation
10/03/2007EP1839669A1 Novel angiogensis inhibitor
10/03/2007EP1839664A1 Agent for regulating bone formation
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1838351A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/03/2007EP1838335A1 Growth factor composition
10/03/2007EP1366161B1 Antagonist anti-pro842 antibody
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/03/2007EP1353672B1 Synthesis of 4-amino-thalidomide enantiomers
10/03/2007EP1267839B1 Microspheres for active embolization
10/03/2007EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases
10/03/2007EP1023081B1 Use of recombinant human uteroglobin in treatment of fibrotic conditions
10/03/2007EP0735896B1 Parathyroid hormone formulation
10/03/2007CN101048428A Methods of using death receptor ligands and CD20 antibodies
10/03/2007CN101048392A Novel use
10/03/2007CN101048165A Process for the preparation of ibandronate
10/03/2007CN101048160A Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
10/03/2007CN101048133A Skin preparation for external use
10/03/2007CN101045141A Medicine for treating neck, shoulder, carina, lumbar vertebra disease
10/03/2007CN101045128A Medicine for treating algomenorrhea
10/03/2007CN101045103A Traditional Chinese medicine for treating arthrolithiasis of fowl; its preparating method and use
10/03/2007CN101045086A Medicine for treating rheumatismal arthritis and its preparing method
10/03/2007CN101045084A Medicine for treating prolapse of lumber intervertebral disc and sciatica
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340548C Novel arylheteroalkylamine derivatives
10/03/2007CN100340294C Remedy for spinal injury containing interleukin-6 antagonist
10/03/2007CN100340270C Medicine for treating postpartum pathogenic-wind affection
10/03/2007CN100340269C Chinese medicinal herb composition for treating fracture
10/03/2007CN100340258C Bone developing powder
10/03/2007CN100340257C Traditional Chinese medicine tincture for reducing inflammation and relieving pain
10/03/2007CN100340245C Bone strengthening oral liquor and its preparing method
10/03/2007CN100340244C Method of implanting heavy method such as nobel metal, E.G. glod, and metal for use in implantation
10/03/2007CN100340243C Use of sodium selenite in preparing medicine for osseous arthritis
10/02/2007US7276604 Stable in humid environments; bone resorption disorders; mixing and heating an aqueous solution of the salt hydrate with isopropanol and crystallizing during slow cooling
10/02/2007US7276528 Compounds for the inhibition of nitric oxide synthase
10/02/2007US7276525 Administering either simultaneously or sequentially a bone morphogenic protein and a compound having a transforming growth factor-beta selective inhibitory activity, particularly 4-(4-benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276509 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic
10/02/2007US7276505 Immunomodulating heterocyclic compounds
10/02/2007US7276481 Method and composition for treatment of skeletal dysplasias
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof
10/02/2007US7276344 Osteoclastogenesis inhibitory factor protein for treating osteoporosis
10/02/2007CA2378369C Small molecules useful in the treatment of inflammatory disease
10/02/2007CA2298033C Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
10/02/2007CA2289509C Novel compounds
09/2007
09/27/2007WO2007107499A1 Quinoline derivatives useful as pde4 inhibitors
09/27/2007WO2007107469A1 Methods of inhibiting btk and syk protein kinases
09/27/2007WO2007092755A3 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
09/27/2007WO2007049088A8 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues
09/27/2007WO2007003200A3 High yield synthesis methods for producing organic salts of strontium